Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 1/20 | 0.43 |
| ▸ | DGKA | P23743 | 1/20 | 0.36 |
| ▸ | KDM5A | P29375 | 6/20 | 0.35 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.34 |
| ▸ | KDM4C | Q9H3R0 | 6/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | KDM4A | O75164 | 2/20 | 0.32 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | HTR2C | P28335 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16728123 | 0.87 | DNM1 (0.47) | DNM1ALDH1A1KDM4E | |
| SCHEMBL10178872 | 0.84 | DGKA (0.38) | DGKAPLA2G4B | |
| SCHEMBL2616693 | 0.80 | MGLL (0.35) | DGKAPLA2G4B | |
| SCHEMBL16638794 | 0.79 | LMNA (0.47) | DNM1DGKAPLA2G4BHTR2C | |
| SCHEMBL18385819 | 0.79 | DNM1 (0.45) | DNM1DGKAKDM5AALDH1A1HTR2C | |
| SCHEMBL2616655 | 0.79 | PLA2G4B (0.39) | DGKAPLA2G4BALDH1A1 | |
| SCHEMBL13260890 | 0.78 | ADRA2A (0.50) | — | |
| SCHEMBL2616695 | 0.78 | PLA2G4B (0.38) | DGKAPLA2G4BALDH1A1 | |
| SCHEMBL10180339 | 0.77 | DNM1 (0.48) | DNM1DGKAPLA2G4BALDH1A1HPGD | |
| SCHEMBL13789646 | 0.75 | ENPP2 (0.34) | DGKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150137666-A1 | REACTIVE IONIC LIQUID, AND ION-IMMOBILIZED METAL OXIDE PARTICLE, ION-IMMOBILIZED ELASTOMER, AND TRANSDUCER USING SAME | SUMITOMO RIKO COMPANY LIMITED (JP) | 2015-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150137666-A1 | REACTIVE IONIC LIQUID, AND ION-IMMOBILIZED METAL OXIDE PARTICLE, ION-IMMOBILIZED ELASTOMER, AND TRANSDUCER USING SAME | L1CAM, ITGA2B, AS3MT | DNM1 3889/4885DGKA 4097/4885KDM5A 2875/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.